Dr. Brian Brinkerhoff is excited to be a faculty member on the GI Pathology Service at OHSU. As a native of the Portland area, he is committed to advancing patient care in the Northwest region through quality diagnostics, clinical collaboration, and dedicated teaching. His particular areas of interest include Barrett’s dysplasia, inflammatory bowel disease, and cancers of the pancreas and biliary system.
Dr. Brinkerhoff received his medical degree from the Medical College of Wisconsin, followed by residency training in Anatomic and Clinical Pathology at OHSU, where he served as Chief Resident. After completing a fellowship in Gastrointestinal, Liver, and Pancreatobiliary Pathology at the University of Utah, he worked in Alberta, Canada before accepting a faculty appointment in the Department of Pathology at OHSU.
Dr. Brinkerhoff returns to the area with his family, and enjoys exploring the natural beauty of the Oregon Coast and Columbia River Gorge.Read more
Areas of interest
- Gastrointestinal, liver, and pancreatobiliary pathology
- Barrett’s dysplasia, inflammatory bowel disease
- M.D., Medical College of Wisconsin, Milwaukee Wisconsin United States 2012
- Chief Resident Anatomic and Clinical Pathology, Oregon Health & Science University, 2015-2016
- Anatomic and Clinical Pathology, Oregon Health & Science University, 2012-2016
- GI Pathology Fellowship, University of Utah, Salt Lake City, Utah, 2017
- Anatomic and Clinical Pathology (American Board of Pathology), 2016
Uses and Limitations of IgG4 Positive Plasma Cells in Evaluating Ulcerative Colitis. Keyashian K, Duregon E, Brinkerhof BT, Bradley L, Larson B, Lim J, Modiano N, Collins J, Morgan TK, Hooper JE. Journal of Gastrointestinal and Liver Diseases. 2017 Dec. PMID: 29253063.
Renal pathology in hematopoietic cell transplant recipients: A contemporary biopsy, nephrectomy, and autopsy series. Brinkerhoff BT, Houghton DC, Troxell ML. Modern Pathology. 2016 Jun. PMID: 27015134.
Long-Term Therapy with Bevacizumab in HHT. Brinkerhoff BT, Poetker DM, Choong NW. New England Journal of Medicine. 2011 Feb. PMID: 21323562.
Intravenous and Topical Intranasal Bevacizumab (Avastin) in Hereditary Hemorrhagic Telangiectasia. Brinkerhoff BT, Choong NW, Treisman JS, Poetker DM. American Journal of Otolaryngology 2012 May-Jun. PMID: 21917353.